Surface-Biofunctionalized Dual-Purpose Scaffolds that Minimize Growth Factor Dependency for Stem Cell Expansion and Delivery
- 23 December 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Abstract
The clinical potential of mesenchymal stromal/stem cells (MSCs) is limited by the mismatch between their low abundance in adult tissue and the high doses required for treatment. Conventional cell expansion systems that rely on repeated supplementation with labile, soluble growth factors are inefficient and costly. Moreover, the majority of transplanted MSCs exhibit poor survival post-delivery, undermining therapeutic outcomes and exacerbating cell supply challenges. Three-dimensional (3D) polymeric scaffolds, with high surface-area-to-volume ratios, offer a promising strategy for enhancing both cell expansion and delivery. However, their bioinert nature and limited functionalization options have hindered translation. Here, we present a dual-purpose macroporous polycaprolactone (PCL) scaffold, homogeneously activated using long-lived surface-embedded radicals, to enable the one-step covalent immobilization of fibroblast growth factor 2 (FGF2) throughout its internal architecture. This approach preserves the degradability of PCL, while enhancing FGF2 stability and bioavailability. The resulting biofunctional scaffold supports labor-efficient, spatially uniform MSC expansion with a 99% reduction in FGF2 usage, compared to serial cultures on planar surfaces in FGF2-supplemented media. In addition, when used as a cell delivery vehicle, the scaffold enhances MSC survival and retention after implantation. The generation of such multifunctional 3D materials has broad implications for improving the feasibility, accessibility, and impact of cell therapies and offers a blueprint for the robust, cost-effective biofunctionalization of other biomedically relevant porous materials.Keywords
Funding Information
- National Health and Medical Research Council (2017233)
- National Heart Foundation of Australia (105622)
- Australian Research Council (ARC) (DE210100662)
- Australian Research Council (ARC) (DP190103507)
- Australian Research Council (ARC) (DP220101644)
This publication has 73 references indexed in Scilit:
- Cold plasma treatment of porous scaffolds: Design principlesPlasma Processes and Polymers, 2022
- Hydrogel−Solid Hybrid Materials for Biomedical Applications Enabled by Surface‐Embedded RadicalsAdvanced Functional Materials, 2020
- Bio-Activation of Polyether Ether Ketone Using Plasma Immersion Ion Implantation: A Kinetic ModelPlasma Processes and Polymers, 2014
- Concise Review: Bone Marrow-Derived Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for Basic Research and the ClinicStem Cells, 2014
- Immobilisation of cell‐binding peptides on poly‐ε‐caprolactone (PCL) films: A comparative XPS study of two chemical surface functionalisation methodsSurface and Interface Analysis, 2014
- Thermal Stability of Fibroblast Growth Factor Protein Is a Determinant Factor in Regulating Self-Renewal, Differentiation, and Reprogramming in Human Pluripotent Stem CellsStem Cells, 2012
- A comparative study of seeding techniques and three-dimensional matrices for mesenchymal cell attachmentJournal of Tissue Engineering and Regenerative Medicine, 2011
- Fabrication and Characterisation of Amine‐Rich Organic Thin Films: Focus on StabilityPlasma Processes and Polymers, 2010
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005
- Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservationJournal of Cellular Biochemistry, 1997